These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 29408358

  • 41. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F, Perez L, de Neira M, Hall AJ.
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [Abstract] [Full Text] [Related]

  • 42. Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study.
    Wang S, Tao Y, Tao Y, Jiang J, Yan L, Wang C, Ding Y, Yu J, Zhao D, Chi X, Wang X, Wu R, Gao X, Shi Y, Guan Y, Li Y, Xing Y, Sun H, Ta C, Wang C, Niu J, Meng J, Xu H.
    BMC Public Health; 2018 Sep 03; 18(1):1088. PubMed ID: 30176842
    [Abstract] [Full Text] [Related]

  • 43. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
    Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM.
    Saudi Med J; 2003 Sep 03; 24(9):991-5. PubMed ID: 12973485
    [Abstract] [Full Text] [Related]

  • 44. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S, Mahmoodi MF, Andalibi S, Solati AA.
    J Trop Med Hyg; 1993 Oct 03; 96(5):277-87. PubMed ID: 8411302
    [Abstract] [Full Text] [Related]

  • 45. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F, Zhang G, Zheng H, Miao N, Shen L, Wang F, Dong P, Du F, Chen C, Zhang X, Cui F.
    Vaccine; 2017 Jul 24; 35(33):4229-4235. PubMed ID: 28651839
    [Abstract] [Full Text] [Related]

  • 46. Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China.
    Shen YZ, Wang ZY, Qi TK, Jiang XY, Song W, Tang Y, Wang JR, Liu L, Zhang RF, Zheng YF, Dai ZS, Lu HZ.
    HIV Med; 2013 Mar 24; 14(3):167-75. PubMed ID: 22998624
    [Abstract] [Full Text] [Related]

  • 47. Epidemiology of hepatitis B virus infection among preconception couples in South China: a cross-sectional study.
    Liang Z, Qiu J, Xiang Q, Yi J, Zhu J, Zhao Q.
    BMJ Open; 2023 Jun 09; 13(6):e061165. PubMed ID: 37295827
    [Abstract] [Full Text] [Related]

  • 48. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F, Ma YJ, Zhou TY, Duan JC, Wang JF, Ji YL, Li H, Zhang JY, Tang H.
    Viral Immunol; 2016 Jun 09; 29(1):40-8. PubMed ID: 26565951
    [Abstract] [Full Text] [Related]

  • 49. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.
    Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y.
    Vaccine; 2009 Nov 05; 27(47):6550-7. PubMed ID: 19729084
    [Abstract] [Full Text] [Related]

  • 50. [Epidemiological characteristics of children aged 1-4 years without timely birth dose of hepatitis B vaccine vaccination in China, 2014].
    Wang FZ, Zhang GM, Shen LP, Liu JH, Zheng H, Wang F, Miao N, Sun XJ, Liang XF, Cui FQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan 10; 38(1):32-36. PubMed ID: 28100373
    [Abstract] [Full Text] [Related]

  • 51. Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.
    Khetsuriani N, Tishkova F, Jabirov S, Wannemuehler K, Kamili S, Pirova Z, Mosina L, Gavrilin E, Ursu P, Drobeniuc J.
    Vaccine; 2015 Jul 31; 33(32):4019-24. PubMed ID: 26072015
    [Abstract] [Full Text] [Related]

  • 52. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F, Robertson PW, LePage AK, Jayamaha J, Baleriola C, Rawlinson WD.
    Pathology; 2013 Aug 31; 45(5):501-5. PubMed ID: 23842045
    [Abstract] [Full Text] [Related]

  • 53. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, Hall AJ.
    BMC Infect Dis; 2014 Jan 07; 14():7. PubMed ID: 24397793
    [Abstract] [Full Text] [Related]

  • 54. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey.
    Davaalkham D, Ojima T, Nymadawa P, Tsend N, Lkhagvasuren T, Wiersma S, Uehara R, Watanabe M, Oki I, Nakamura Y.
    Pediatr Int; 2007 Jun 07; 49(3):368-74. PubMed ID: 17532838
    [Abstract] [Full Text] [Related]

  • 55. [Analysis on sero-epidemiological characteristics of hepatitis B virus among people born during 1994-2001 before and after hepatitis B vaccine catch-up vaccination, China].
    Wang FZ, Zheng H, Miao N, Sun XJ, Zhang GM, Liang XF, Cui FQ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun 06; 51(6):469-474. PubMed ID: 28592087
    [Abstract] [Full Text] [Related]

  • 56. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.
    Arch Virol; 2016 Dec 06; 161(12):3405-3411. PubMed ID: 27613286
    [Abstract] [Full Text] [Related]

  • 57. Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.
    Cabezas C, Trujillo O, Balbuena J, Peceros FM, Terrazas M, Suárez M, Marin L, Apac J, Ramírez-Soto MC.
    PLoS One; 2020 Dec 06; 15(8):e0236993. PubMed ID: 32760100
    [Abstract] [Full Text] [Related]

  • 58. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
    Baruti K, Lentz K, Anderson M, Ajibola G, Phinius BB, Choga WT, Mbangiwa T, Powis KM, Sebunya T, Blackard JT, Lockman S, Moyo S, Shapiro R, Gaseitsiwe S.
    PLoS One; 2020 Dec 06; 15(8):e0237252. PubMed ID: 32764801
    [Abstract] [Full Text] [Related]

  • 59. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme.
    Shen LP, Zhang Y, Wang F, Zhang S, Yang JY, Fang KX, Yu T, Wang XY, Zhang WY, Bi SL.
    Epidemiol Infect; 2011 Aug 06; 139(8):1159-65. PubMed ID: 21156099
    [Abstract] [Full Text] [Related]

  • 60. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
    Ni YH, Chang MH, Jan CF, Hsu HY, Chen HL, Wu JF, Chen DS.
    Clin Gastroenterol Hepatol; 2016 Sep 06; 14(9):1324-30. PubMed ID: 27155556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.